OutreAch MediCal Care for HousEbound Patients With Post-COVID-19 Syndrome or ME/CFS of Any Cause (ACCESS)
- NCT ID
- NCT07352254
- Registry status
- Recruiting
- Study type
- Not specified in the registry data
- Phase
- Not applicable
- Sponsor
- Hannover Medical School
Overview
ClinicalTrials.gov lists this study as Recruiting.
Enrollment: 100 participants (Estimated).
What is being studied
No interventions are listed in the registry data.
Who may be eligible
- Ages
- Not specified in the registry data
- Sex
- Not specified in the registry data
- Healthy volunteers accepted
- No
ClinicalTrials.gov lists the following eligibility criteria.
Inclusion Criteria:
* ME/CFS according to the Canadian Consensus Criteria
* Bell Score ≤ 30
* Duration of the postexertional malaise (PEM) \> 14 hours
* Age \> 18 years and \< 70
Exclusion Criteria:
\- Pre-existing conditions or comorbidities that have (or could have) led to a restriction of mobility or mental capacity, such as various diseases of the central nervous system.
Study locations
1 study location is listed.
Site recruitment status is not specified in the registry data for these locations.
Countries: Germany
Sample of listed locations
- Hannover Medical School — Hanover, 30625, Germany — Site recruitment status not specified in the registry data
Study details
- Start date
- January 1, 2026
- Primary completion date
- October 1, 2028
- First posted
- January 20, 2026
Source and update information
- Source
- ClinicalTrials.gov
- NCT ID
- NCT07352254
- Registry last updated
- January 21, 2026
- QualifiedStudies registry data refreshed
- September 21, 2026
View NCT07352254 on ClinicalTrials.gov
Trial information can change. Confirm current study details with the study team or the registry.
About joining clinical research
Find clinical trials you may match with
QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.
Find clinical trials you may match with | Chronic Fatigue Syndrome (CFS) studies | Clinical trial FAQ